Medical Devices Startups
6,515 companies tagged Medical Devices, with their investors and founders.
JARMeC operates advanced-care animal hospitals that provide specialized veterinary medicine across 12 clinical departments, working in partnership with primary-care veterinary clinics. Founded in 2005, it offers 365-day emergency and referral care for pets in Japan.
1 investor
Soiken Holdings is a biotech venture originating from Osaka University's medical faculty that develops and commercializes biomarker technologies and systems for objective health assessment across food, pharmaceutical, and healthcare applications.
1 investor
Bushu Pharma is a contract development and manufacturing organization (CDMO) that provides contract manufacturing of pharmaceutical products, with GMP certifications from major countries and exports to 56 nations. It serves pharmaceutical clients as a specialist in outsourced drug manufacturing for global markets.
1 investor
Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices. Founded in 2004 and publicly listed (300347.SZ / 3347.HK), it provides services including clinical monitoring, regulatory affairs, data management, and site management.
1 investor
Kubota Holdings is an ophthalmic healthcare solutions company focused on developing pharmaceuticals and medical devices to help maintain and restore vision for people with eye diseases. The group engages in the research and development of treatments and medical technologies for ocular conditions.
1 investor
Uni-medica develops automated fluorescence staining and analysis systems, nucleic acid detection kits, and high-throughput sequencing products for molecular diagnostic applications including cervical cancer screening, pathogen detection, and genetic disease identification. The company serves hospitals and medical laboratories in China.
1 investor
Mindray develops medical devices for hospitals and clinicians, including the N-Series patient monitors designed for high-acuity care with modular hardware and connectivity features. It serves healthcare providers across various care settings worldwide.
1 investor
3Daughters develops a frameless, non-hormonal intrauterine contraceptive device (IUD) designed to reduce insertion pain and improve the user experience for women. The company is preparing clinical trials for its magnetic IUD platform and exploring applications in targeted uterine drug delivery.
0 investors
3Spine develops MOTUS, a lumbar total joint replacement device that replaces the function of the spinal disc and facet joints as an alternative to spinal fusion for treating leg and back pain. The technology is designed to preserve range of motion and correct sagittal balance, and the company is pursuing FDA commercial approval in the US.
0 investors
4C Medical develops minimally invasive medical devices for structural heart disease, including mitral and tricuspid valve treatments. The company serves interventional cardiologists and patients requiring catheter-based cardiac interventions.
0 investors
4WEB Medical designs titanium interbody spinal fusion implants using a truss-based structural design produced through additive manufacturing (3D printing). Its products include stand-alone and lateral spine systems intended to support the fusion process and improve patient outcomes.
0 investors
A28 Therapeutics develops a targeted oncolytic peptide platform for treating multiple cancer types, with its lead candidate AT-101 in late-stage development for metastatic ovarian cancer with liver metastases and hepatocellular carcinoma. The company is also exploring combinations of AT-101 with immuno-oncology drugs and chemotherapy.
0 investors
Aatru Medical is a medical device company that develops wound care products, including NPSIMS, a negative pressure wound therapy (NPWT) system for surgical incision management aimed at reducing surgical site complications. Its products serve clinicians and patients, and the company is the parent of Exothermix, which supplies the oxygen scavenger used in NPSIMS.
0 investors
Abfero Pharmaceuticals is a clinical-stage pharmaceutical company developing oral iron chelators that target iron as a therapeutic pathway for diseases of iron overload. Its lead brain-penetrant small molecule, SP-420, is aimed at conditions such as transfusional systemic iron overload and age-related macular degeneration.
0 investors
Absco Therapeutics develops a drug delivery platform based on thermogelling polymers that shift from liquid to solid at body temperature to form controlled-release depots for sustained, on-target therapy. Its lead candidate ABS005 is a non-surgical intralesional treatment for high-grade cervical intraepithelial neoplasia (CIN2/3), with the platform targeting cancers and precancers.
0 investors
ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
0 investors
Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases. It serves international public health agencies and organizations.
0 investors
Accure develops an FDA-cleared, CE Mark–approved laser system that treats inflammatory acne by selectively targeting overactive sebaceous glands while sparing surrounding skin. The device is designed for dermatologists and acne patients, using a "treat-to-temperature" algorithm intended to work across all skin types.
0 investors
AccurKardia develops AI-based technology for cardiac monitoring and ECG interpretation, serving clinicians and healthcare providers. It operates in the cardiology-focused medtech and digital health space.
0 investors
AccuVein manufactures vein visualization systems for medical professionals to locate veins during procedures. The company serves healthcare providers in clinical and procedural settings.
0 investors
Achelios Therapeutics develops therapies for chronic pain conditions including temporomandibular joint pain, migraine, and arthritis-related joint pain through repurposed and reformulated drug candidates. The company addresses unmet medical needs in chronic pain that have been underserved by larger pharmaceutical firms.
0 investors
Aclarion develops NOCISCAN, a SaaS platform that uses MR spectroscopy to noninvasively help physicians distinguish painful from nonpainful spinal discs in patients with chronic low back pain. It complements conventional lumbar MRI with pain biomarker data and per-disc NOCI+/NOCI- scores to support treatment and surgical planning.
0 investors
Aclipse Therapeutics is a clinical-stage biopharmaceutical company developing disease-modifying drug candidates for life-threatening neuromuscular and severe diseases, using genomic, proteomic, and biomarker data. Its lead programs include M107 for gastroparesis and M102 for amyotrophic lateral sclerosis (ALS).
0 investors
Acomhal Research develops a peptide drug designed to target and eliminate cancer stem cells, preventing tumor recurrence and metastasis across multiple cancer types including glioblastoma, breast cancer, and others. The company operates in the biotech sector, focusing on novel therapeutics for drug-resistant cancers.
0 investors